Research library
Sources, with the status on the record.
Each row is a paper or a ClinicalTrials.gov entry checked on 21 November 2026. Titles are the authors’ or the registry’s words. Nalen Lab does not restate them as claims about these products. A registration is not a result.
Records checked 2026-11-21. Open registry rows in this view: 0. Selank has published papers and no verified intervention trial.
Loading filters…
PT-141
2022
Publication
Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.
Simon JA et al. · Journal of Women's Health
PublishedSame compound as the catalogue listing
Phase 3 analyses of the authorised medicine bremelanotide. The title is the authors' wording.
View in the catalogue